RSMj 2022 6th Annual Scientific Meeting
July 22-24, 2022
The 2022 RSMj Annual Meeting was held in-person from July 22-24, 2022 at Boston University (BU). A special thank you to our keynote speakers, Dr. Marsha Lopez and Dr. Robert Miranda, Jr., and all attendees for their contributions – Hope to see you in 2023 in Long Beach, CA!
Below, view the conference program and keynote speaker details.
Marsha Lopez, Ph.D.
Epidemiology Research Branch
National Institute on Drug Abuse
Dr. Lopez is currently Chief of the Epidemiology Research Branch. Prior to becoming Branch Chief, her program areas included major epidemiological studies and secondary data analysis, studies of the co-occurrence of drug and other psychiatric disorders, diagnostic issues pertaining to drug and other psychiatric conditions. Dr. Lopez is the Program Official for the Monitoring the Future Study, as well as an active supporter of Research Training among new investigators. After receiving her B.A. in Psychology from Georgetown University, Dr. Lopez was an Intramural Research Training Associate (IRTA) Fellow at NIDA for two years in Behavioral Pharmacology in the Preclinical Pharmacology Laboratory. She subsequently attended the Johns Hopkins University School of Hygiene and Public Health, Department of Mental Hygiene, where she received her MHS with a concentration in Public Mental Health, and then Ph.D. with a focus on drug and alcohol dependence epidemiology. Her training was funded by an Individual National Research Service Award (NRSA) from NIDA, supporting research on drug related mortality.
Robert Miranda, Jr., Ph.D.
Professor of Psychiatry and Human Behavior
Center for Alcohol and Addiction Studies
Dr. Miranda is a Professor of Psychiatry & Human Behavior. He has committed his career as a clinician scientist to advancing our understanding of how addiction develops and progresses during adolescence, with the ultimate goal of advancing clinical practice. He directs a federally funded research program on the treatment of adolescents with substance use and co-occurring mental health disorders, with a special focus on testing new pharmacological interventions and using novel strategies to monitor how adolescents behave in their natural environment. He has served as Principal Investigator, Co-Investigator, or Mentor on over 30 federally funded research projects, and has developed several novel assessment and intervention approaches for adolescents with substance use and co-occurring mental health disorders. In addition, Dr. Miranda has served on numerous study sections at the National Institutes of Health.